ID: ALA326717

Max Phase: Preclinical

Molecular Formula: C13H19N5

Molecular Weight: 245.33

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  CC1(C)N=C(N)N=C(N)N1CCc1ccccc1

Standard InChI:  InChI=1S/C13H19N5/c1-13(2)17-11(14)16-12(15)18(13)9-8-10-6-4-3-5-7-10/h3-7H,8-9H2,1-2H3,(H4,14,15,16,17)

Standard InChI Key:  JBJTVKGLJGIQAQ-UHFFFAOYSA-N

Associated Targets(non-human)

Dihydrofolate reductase type 1 145 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 245.33Molecular Weight (Monoisotopic): 245.1640AlogP: 0.91#Rotatable Bonds: 3
Polar Surface Area: 80.00Molecular Species: BASEHBA: 5HBD: 2
#RO5 Violations: 0HBA (Lipinski): 5HBD (Lipinski): 4#RO5 Violations (Lipinski): 0
CX Acidic pKa: CX Basic pKa: 10.26CX LogP: 1.29CX LogD: -0.75
Aromatic Rings: 1Heavy Atoms: 18QED Weighted: 0.83Np Likeness Score: -0.25

References

1. Ghose AK, Crippen GM..  (1985)  Use of physicochemical parameters in distance geometry and related three-dimensional quantitative structure-activity relationships: a demonstration using Escherichia coli dihydrofolate reductase inhibitors.,  28  (3): [PMID:3882967] [10.1021/jm00381a013]

Source